483
GenIbet Biopharmaceuticals, S.A.GenIbet Biopharmaceuticals, S.A. – FDA 483
Record Details
An FDA inspection of Genibet Biopharmaceuticals SA in Oeiras, Portugal, identified significant deficiencies across multiple areas of their drug manufacturing operations. The firm lacks adequate written procedures and supporting data for production and process controls, raising concerns about product quality and purity. Additionally, critical issues were noted with equipment cleaning processes and decontamination procedures, indicating a risk of cross-contamination.
- Product type
- drugs
View Company Profile
ID · eaf6a5e6-7b22-4e2c-a385-4efa0a572196
Other documents for GenIbet Biopharmaceuticals, S.A.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.